TY - JOUR
T1 - Thread embedding acupuncture for herniated intervertebral disc of the lumbar spine
T2 - A multicenter, randomized, patient-assessor-blinded, controlled, parallel, clinical trial
AU - Goo, Bonhyuk
AU - Kim, Jung Hyun
AU - Kim, Eun Jung
AU - Lee, Hyun Jong
AU - Kim, Jae Soo
AU - Nam, Dongwoo
AU - Park, Yeon Cheol
AU - Kim, Tae Hun
AU - Baek, Yong Hyeon
AU - Nam, Sang Soo
AU - Seo, Byung Kwan
N1 - Funding Information:
This study was supported by the Traditional Korean Medicine R&D program funded by the Ministry of Health & Welfare through the Korea Health Industry Development Institute (KHIDI) (HB16C0061).
Publisher Copyright:
© 2022 Elsevier Ltd
PY - 2022/2
Y1 - 2022/2
N2 - Background: and purpose: Although several studies have reported that thread embedding acupuncture (TEA) is effective for lumbar herniated intervertebral disc (LHIVD), the evidence remains limited because previous studies had a high risk of bias. This study aimed to investigate the efficacy and safety of TEA for LHIVD through a rigorously designed trial. Materials and methods: This was a randomized, patient-assessor-blinded, sham-controlled trial. Participants were screened according to eligibility criteria, and 70 patients with LHIVD were randomly allocated to the TEA and sham TEA (STEA) groups in a 1:1 ratio. Both groups received TEA or STEA treatment at 23 acupoints once per week for eight weeks. Changes in low back pain, radiating pain, Oswestry disability index, Roland–Morris disability questionnaire, EuroQol 5–Dimensions 5–Levels, and global perceived effect were measured at baseline and at 4, 8, 12, and 16 weeks after screening and compared between the two groups. Results: TEA showed no significant difference in all outcomes compared to STEA immediately after eight weeks of treatment. After an additional eight weeks of follow-up, TEA showed a more significant effect on the low back pain than STEA (p < 0.05) and showed a better tendency in maintaining or enhancing the improvement of radiating pain, function, and quality of life even after the end of treatment. No serious adverse events were observed. Conclusion: TEA is effective in improving low back pain in patients with LHIVD and may help improve function and quality of life, especially in the long term.
AB - Background: and purpose: Although several studies have reported that thread embedding acupuncture (TEA) is effective for lumbar herniated intervertebral disc (LHIVD), the evidence remains limited because previous studies had a high risk of bias. This study aimed to investigate the efficacy and safety of TEA for LHIVD through a rigorously designed trial. Materials and methods: This was a randomized, patient-assessor-blinded, sham-controlled trial. Participants were screened according to eligibility criteria, and 70 patients with LHIVD were randomly allocated to the TEA and sham TEA (STEA) groups in a 1:1 ratio. Both groups received TEA or STEA treatment at 23 acupoints once per week for eight weeks. Changes in low back pain, radiating pain, Oswestry disability index, Roland–Morris disability questionnaire, EuroQol 5–Dimensions 5–Levels, and global perceived effect were measured at baseline and at 4, 8, 12, and 16 weeks after screening and compared between the two groups. Results: TEA showed no significant difference in all outcomes compared to STEA immediately after eight weeks of treatment. After an additional eight weeks of follow-up, TEA showed a more significant effect on the low back pain than STEA (p < 0.05) and showed a better tendency in maintaining or enhancing the improvement of radiating pain, function, and quality of life even after the end of treatment. No serious adverse events were observed. Conclusion: TEA is effective in improving low back pain in patients with LHIVD and may help improve function and quality of life, especially in the long term.
KW - Intervertebral disc displacement
KW - Low back pain
KW - Lumbar vertebrae
KW - Randomized controlled trial
KW - Thread embedding acupuncture
UR - http://www.scopus.com/inward/record.url?scp=85123729220&partnerID=8YFLogxK
U2 - 10.1016/j.ctcp.2022.101538
DO - 10.1016/j.ctcp.2022.101538
M3 - Article
C2 - 35101704
AN - SCOPUS:85123729220
VL - 46
JO - Complementary Therapies in Clinical Practice
JF - Complementary Therapies in Clinical Practice
SN - 1744-3881
M1 - 101538
ER -